DataM Intelligence Projects In-Silico Clinical Trials Market to Reach $6.39 Billion by 2033

Nov 27, 2025
According to DataM Intelligence, the in-silico clinical trials market is expected to grow from $3.95 billion in 2024 to $6.39 billion by 2033, driven by AI-based modeling and virtual patient simulations.

The in-silico clinical trials market is projected to reach USD 6.39 billion by 2033, up from USD 3.95 billion in 2024, expanding at a compound annual growth rate of 5.5% between 2025 and 2033, announced in a press release by DataM Intelligence.

In-silico trials use computational modeling, virtual patient simulations, and AI-driven predictive systems to digitally test drug candidates, medical devices, and treatment protocols. These digital simulations complement laboratory and clinical studies by improving prediction accuracy and reducing experimental workloads.

The report highlights that pharmaceutical companies, medical device manufacturers, contract research organizations, and academic institutions are increasingly adopting in-silico trial platforms to modernize clinical development. The approach helps address challenges such as high development costs, regulatory delays, and patient recruitment difficulties, ultimately shortening the time to market for new therapies.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Healthcare & Life Sciences AI AI Brief AI Brief (X)
Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

AI Token Webinar

Whitepaper

Tensordyne Napier: What If One Rack Could Do the Work of Nine?

Tensordyne

This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.

Read more

You may also like

Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.